(MENAFN- IMARC Group) According to IMARC Group’s latest report, titled “Acne Drugs Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global acne drugs market reached a value of US$ 4.82 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 4.4% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Acne drugs are medications used to treat a dermatological infection caused by the inflammation in the hair follicles on the skin. It is generally due to hormonal imbalance, oily skin, accumulation of dead skin cells, bacteria, stress, inadequate water intake, and excessive consumption of sugars, salts, or carbohydrates. Few acne drugs are topical medications, such as retinoids, salicylic and azelaic acid-based ointments, and dapsone-based gels, coupled with antibiotics, anti-androgen agents, and isotretinoin. These drugs reduce oil production in the body, accelerate skin cell turnover, reduce acne breakouts, scarring, damage the skin, and prevent inflammation.
Market Trends
The growing incidences of skin-related diseases, such as acne vulgaris, are driving the acne drug market. Moreover, increasing awareness towards the benefits of using premium skin care products and the emergence of effective therapeutics and treatments with lower side effects are augmenting the market growth. Additionally, the growing traction for products containing natural ingredients has compelled the manufacturers to develop products infused with natural herbs and organic ingredients to treat acne. Furthermore, elevating consumer disposable income levels and the growing popularity of customized acne drugs as per the user’s skin type, are expected to propel the acne drugs market.
List of Key Companies Covered in this Market Report:
Allergan Plc
Bausch Health Companies Inc.
Bayer Aktiengesellschaft
Cipher Pharmaceuticals Inc.
Galderma Holding SA
Johnson & Johnson
Pfizer Inc.
Reckitt Benckiser Group Plc
Skinvisible Pharmaceuticals Inc.
Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd
The report has segmented the market on the basis of acne type, drug class, drug type, route of administration and region.
Breakup by Acne Type:
Comedonal
Inflammatory
Cystic
Postsurgical/Wound
Breakup by Drug Class:
Retinoids
Antibiotics
Hormonal Agents
Combination Drugs
Others
Breakup by Drug Type:
OTC Drugs
Prescription Drugs
Breakup by Route of Administration:
Topical
Oral
Injectable
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Key highlights of the report:
Market Performance (2014-2019)
Market Outlook (2020- 2025)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
MENAFN04082021004122009559ID1102565732
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.